ストックスクリーナーアプリを入手
0.9696
7.66%
-0.0804
アフターアワーズ：
.98
0.0104
+1.07%
Polyrizon Ltd (PLRZ) 最新ニュース
Best Biotech Stocks To Research – July 15th - Defense World
Polyrizon Plunges 11.06% Amid Market Challenges - AInvest
Polyrizon Stock Slides After Hours After 52% Surge On Tuesday: Why It Moved - Benzinga
Polyrizon Retains Nasdaq Listing Following Hearings Panel - 富途牛牛
How Polyrizon Ltd. stock performs during market volatilitySmart Trading With Safety Margin - Newser
What makes Polyrizon Ltd. stock price move sharplyFree High-Accuracy Stock Picks - Newser
Polyrizon retains Nasdaq listing following hearings panel - MSN
Polyrizon secures continued Nasdaq listing after panel hearing By Investing.com - Investing.com Nigeria
Polyrizon secures continued Nasdaq listing after panel hearing - Investing.com
Polyrizon Ltd. Secures Continued Nasdaq Listing Following Compliance Plan Implementation - Quiver Quantitative
Why Polyrizon Ltd. stock attracts strong analyst attentionFast Moving Stock Alerts - Newser
Polyrizon, Pheton, AirSculpt: Top 3 Healthcare Stocks With Soaring Weekly Retail Interest - MSN
Polyrizon Ltd. Announces Board Changes and Confirms Independent Directors - The Globe and Mail
Polyrizon director Omer Srugo resigns; board affirms independent members - Investing.com
Polyrizon Ltd Inc. (PLRZ) Price Performance: How to Use Technical Analysis to Make Trading Decisions - investchronicle.com
Polyrizon’s nasal drug delivery system shows promising results By Investing.com - Investing.com South Africa
Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics - MarketScreener
Polyrizon’s nasal drug delivery system shows promising results - Investing.com Australia
Polyrizon Announces Promising Preclinical Results for CNS Therapeutics - TipRanks
Revolutionary Nasal Drug Delivery System Could Transform Treatment of Opioid Overdose and Epilepsy - Stock Titan
Xylo Technologies: Viewbix Shares to Begin Trading on Nasdaq - GlobeNewswire
Smart Digital Group And Polyrizon See Unusual Market Moves - Finimize
Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Polyrizon Soars 14.55% Post Reverse Stock Split - AInvest
Polyrizon Ltd. Announces Reverse Share Split Effective May 27, 2025 - TipRanks
Polyrizon recives Nasdaq delisting notice - MSN
Polyrizon faces Nasdaq delisting over shareholder dilution - Investing.com Australia
Polyrizon Stock Price, Quotes and Forecasts | NASDAQ:PLRZ - Benzinga
Polyrizon faces Nasdaq delisting over shareholder dilution By Investing.com - Investing.com India
Polyrizon Receives Nasdaq Delisting Notice Amid Shareholder Concerns - TipRanks
Polyrizon Receives Nasdaq Delisting Notice - marketscreener.com
Polyrizon receives noncompliance letter from Nasdaq - TipRanks
Polyrizon Announces Receipt of Nasdaq Delisting Notice - The Manila Times
Polyrizon announces preclinical data on nasal protection platform - TipRanks
Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform - Bluefield Daily Telegraph
Revolutionary Nasal Drug Delivery Platform Achieves Perfect Coverage Score in Latest Tests - Stock Titan
Pennies on the Rise: HCTI, SWISF, ADHC, NCNA Gain Traction Amid LargeCap Uncertainty – More Stocks Inside - FinancialContent
Polyrizon Ltd. Increases Outstanding Shares Following Warrant Exercises - TipRanks
Polyrizon Ltd. Announces Increase in Outstanding Shares Following Warrant Exercises - TipRanks
Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings - Benzinga
Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales - Benzinga
Polyrizon begins preclinical studies for seizure treatment - Investing.com Australia
Polyrizon announces initiation of preclinical studies for Benzodiazepines - TipRanks
Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment - The Manila Times
Polyrizon begins preclinical studies for seizure treatment By Investing.com - Investing.com Nigeria
0.64%
0.37%
大文字化:
|
ボリューム (24 時間):